Clinical Trials Browser

Withdrawn × Colorectal Neoplasms × futuximab × Clear all

NCT03717038 2019-02-04

Sym004 Versus TAS-102 in Patients With mCRC

Phase 3 Withdrawn

Gastrointestinal

Carcinoma, Colorectal Neoplasms

NCT02965417 2017-02-01

Sym004 in Metastatic Colorectal Cancer and ECD-EGFR Patients

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms